(Q51343483)

3 April 2018

title

A critique of the 2012 ADA/EASD position statement. (English)

1 reference

3 April 2018

2

P S Jellinger

1 reference

3 April 2018

author name string

H W Rodbard

series ordinal

1

1 reference

3 April 2018

publication date

18 July 2012

1 reference

3 April 2018

published in

Diabetologia

1 reference

3 April 2018

volume

55

1 reference

3 April 2018

issue

10

1 reference

3 April 2018

page(s)

2850-2852

1 reference

3 April 2018

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2646-6

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2646-6

Economic costs of diabetes in the U.S. In 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2646-6

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2646-6

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2646-6

Hypoglycemia rates with basal insulin analogs

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22801905

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00125-012-2646-6

1 reference

3 April 2018

1 reference

3 April 2018